FDA Greenlights Second COVID Booster for Select Groups

(MedPage Today) -- A second booster dose of Pfizer or Moderna's COVID-19 vaccine was authorized for adults ages 50 and up, as well as certain populations at risk for severe disease, the FDA said on Tuesday.
In a highly anticipated emergency use...